Najat Khan, CEO and President: Recursion Pharmaceuticals RXRX Planned sale · Filed 25/08/18

Trade details

Type: Planned sale notice
Stock: Recursion Pharmaceuticals RXRX
Person: Najat KhanCEO and President
Planned sale date: 25/08/18
Filed: 25/08/18

$202.2K to be sold

Recursion Pharmaceuticals trades, last 26 weeks

What else happened in Recursion Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/07/19~25/09/17

Najat Khan's recent trades

Najat KhanCEO and President
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$78.8K
22,408 sh
$78.8K
Filed 09/08
Traded 09/08
Najat KhanCEO and President
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$84.4K
23,588 sh
$84.4K
Filed 06/05
Traded 06/05
Najat KhanCEO and President
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$84.5K
23,588 sh
$84.5K
Filed 06/05
Traded 06/05
Najat KhanCEO and President
Sell10b5-1 planRecursion Pharmaceuticals
Sell10b5-1 plan
Recursion Pharmaceuticals
RXRX
$94.8K
28,298 sh
$94.8K
Filed 03/11
Traded 03/09
Najat KhanCEO and President
Planned sale10b5-1 planRecursion Pharmaceuticals
Planned sale10b5-1 plan
Recursion Pharmaceuticals
RXRX
$94.7K
28,298 sh
$94.7K
Filed 03/09
Traded 03/09

Najat Khan, CEO — plans to sell 36,599 sh of Recursion Pharmaceuticals RXRX · $202.2K · around 08/18 | Whalegun